154 related articles for article (PubMed ID: 37643778)
1.
He XU; Yu Y; Zhang X; Gao C; Wang H; Liu C
Cancer Genomics Proteomics; 2023; 20(5):476-486. PubMed ID: 37643778
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
3. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
Zhuo X; Dai H; Yu S
Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
[TBL] [Abstract][Full Text] [Related]
4. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
7. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
8. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
9. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
[TBL] [Abstract][Full Text] [Related]
10. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
Front Immunol; 2022; 13():992626. PubMed ID: 36311724
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma.
Qin RX; Yang Y; Chen JF; Huang LJ; Xu W; Qin QC; Liang XJ; Lai XY; Huang XY; Xie MS; Chen L
Front Neurol; 2023; 14():1119160. PubMed ID: 37265472
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
[TBL] [Abstract][Full Text] [Related]
14. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
15. Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network.
Zhang J; Chen A; Xue Z; Liang C
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):334-346. PubMed ID: 36351297
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
17. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
PeerJ; 2023; 11():e16166. PubMed ID: 37790630
[TBL] [Abstract][Full Text] [Related]
18. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Dai D; Shi R; Han S; Jin H; Wang X
Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
[TBL] [Abstract][Full Text] [Related]
19. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
20. Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma.
Li Q; Tang Y; Wang T; Zhu J; Zhou Y; Shi J
J Cancer Res Clin Oncol; 2023 Jan; 149(1):307-323. PubMed ID: 36575346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]